These medications undergo strict FDA testing, ensuring you receive high-quality, consistent results
Linaclotide (Linzess): This medication increases fluid secretion in the small intestine and accelerates bowel movements
10.1517/17425255.2012.686603 166 ScheenA
Less frequent manifestations include tremor, agitation, coma, ataxia, hypertension, slurred speech, confusion, dizziness, nausea, vomiting, and hallucinations
Most patients see steady, manageable weight loss over the first 12 weeks, especially when they combine the medication with healthy eating, movement, and consistent support
Patients on rapid titration schedules report longer fatigue periods than those using gradual dose increases